EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY-NC-ND 4.0

Aplastic Anaemia in a Chronic Lymphocytic Leukaemia Patient Treated With Acalabrutinib, a Bruton Tyrosine Kinase Inhibitor—Case Report

Zachray Wei, Tamara Marconi, Lucy Tuck, Stephen Ting

eJHaem · 2026-10 · 7 (5)

DOI: 10.1002/jha2.70423 ↗

Kurz gefasst

Fallbericht in der Zeitschrift eJHaem, online erschienen am 09.10.2026. Verfasst von Zachray Wei und 3 weiteren Autor:innen. Beteiligte Einrichtung: Eastern Health Box Hill Victoria Australia. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 14 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Although Immune cytopenias such as immune thrombocytopenia (ITP), autoimmune haemolytic anaemia (AIHA) and pure red blood cell aplasia (PRCA) are well documented associations with chronic lymphocytic leukaemia (CLL), aplastic anaemia (AA) is seemingly rare. Case This report describes a case of AA in a CLL patient post commencement of acalabrutinib, a bruton tyrosine kinase inhibitor (BTKi).

Discussion

We further evaluate the current literature surrounding AA in concurrent lymphoproliferative disorders as well as previous cases in the setting of tyrosine kinase inhibition. Highlighting the potential pathophysiological pathways of T regulatory cell dysfunction resulting in immune targeting of haematopoietic stem progenitor cells, we explore the resultant AA as an aberrant immune response secondary to CLL and/or the inhibition of BTKi. Trial Registration The authors have confirmed clinical trial registration is not needed for this submission.

Schlagwörter

Stichwörter der Autor:innen

aplastic anaemiabruton tyrosine kinase inhibitorcase reportchronic lymphocytic leukaemiahaematology

Autor:innen und Institutionen

  • Eastern Health Box Hill Victoria Australia.

Zitieren

APA

Wei, Z., Marconi, T., Tuck, L., & Ting, S. (2026). Aplastic Anaemia in a Chronic Lymphocytic Leukaemia Patient Treated With Acalabrutinib, a Bruton Tyrosine Kinase Inhibitor—Case Report. eJHaem, 7(5). https://doi.org/10.1002/jha2.70423

Vancouver

Wei Z, Marconi T, Tuck L, Ting S. Aplastic Anaemia in a Chronic Lymphocytic Leukaemia Patient Treated With Acalabrutinib, a Bruton Tyrosine Kinase Inhibitor—Case Report. eJHaem. 2026;7(5). doi:10.1002/jha2.70423

BibTeX
@article{Wei2026,
  author = {Wei, Zachray and Marconi, Tamara and Tuck, Lucy and Ting, Stephen},
  title = {Aplastic Anaemia in a Chronic Lymphocytic Leukaemia Patient Treated With Acalabrutinib, a Bruton Tyrosine Kinase Inhibitor—Case Report},
  journal = {eJHaem},
  year = {2026},
  volume = {7},
  number = {5},
  doi = {10.1002/jha2.70423}
}
Kostenlos starten →